279 related articles for article (PubMed ID: 23469940)
1. Glucose tolerance and beta-cell function in islet autoantibody-positive children recruited to a secondary prevention study.
Andersson C; Carlsson A; Cilio C; Cedervall E; Ivarsson SA; Jonsdottir B; Jönsson B; Larsson K; Neiderud J; Lernmark A; Elding Larsson H;
Pediatr Diabetes; 2013 Aug; 14(5):341-9. PubMed ID: 23469940
[TBL] [Abstract][Full Text] [Related]
2. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes.
Andersson C; Vaziri-Sani F; Delli A; Lindblad B; Carlsson A; Forsander G; Ludvigsson J; Marcus C; Samuelsson U; Ivarsson S; Lernmark A; Larsson HE;
Pediatr Diabetes; 2013 Mar; 14(2):97-105. PubMed ID: 22957668
[TBL] [Abstract][Full Text] [Related]
3. Baseline heterogeneity in glucose metabolism marks the risk for type 1 diabetes and complicates secondary prevention.
Elding Larsson H; Larsson C; Lernmark Å;
Acta Diabetol; 2015 Jun; 52(3):473-81. PubMed ID: 25381193
[TBL] [Abstract][Full Text] [Related]
4. Beta cell function in participants with single or multiple islet autoantibodies at baseline in the TEDDY Family Prevention Study: TEFA.
Martinez MM; Salami F; Larsson HE; Toppari J; Lernmark Å; Kero J; Veijola R; Koskenniemi JJ; Tossavainen P; Lundgren M; Borg H; Katsarou A; Maziarz M; Törn C;
Endocrinol Diabetes Metab; 2021 Apr; 4(2):e00198. PubMed ID: 33855205
[TBL] [Abstract][Full Text] [Related]
5. The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes.
Andersson C; Larsson K; Vaziri-Sani F; Lynch K; Carlsson A; Cedervall E; Jönsson B; Neiderud J; Månsson M; Nilsson A; Lernmark A; Elding Larsson H; Ivarsson SA
Autoimmunity; 2011 Aug; 44(5):394-405. PubMed ID: 21244337
[TBL] [Abstract][Full Text] [Related]
6. Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes.
Brorsson C; Vaziri-Sani F; Bergholdt R; Eising S; Nilsson A; Svensson J; Lernmark Å; Pociot F;
Autoimmunity; 2011 Mar; 44(2):107-14. PubMed ID: 20836749
[TBL] [Abstract][Full Text] [Related]
7. Class II HLA Genotype Association With First-Phase Insulin Response Is Explained by Islet Autoantibodies.
Koskinen MK; Lempainen J; Löyttyniemi E; Helminen O; Hekkala A; Härkönen T; Kiviniemi M; Simell O; Knip M; Ilonen J; Toppari J; Veijola R
J Clin Endocrinol Metab; 2018 Aug; 103(8):2870-2878. PubMed ID: 29300921
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children.
Achenbach P; Hummel M; Thümer L; Boerschmann H; Höfelmann D; Ziegler AG
Diabetologia; 2013 Jul; 56(7):1615-22. PubMed ID: 23539116
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of beta-cell function in subjects with multiple islet autoantibodies in the TEDDY family prevention study - TEFA.
Martinez MM; Spiliopoulos L; Salami F; Agardh D; Toppari J; Lernmark Å; Kero J; Veijola R; Tossavainen P; Palmu S; Lundgren M; Borg H; Katsarou A; Larsson HE; Knip M; Maziarz M; Törn C;
Clin Diabetes Endocrinol; 2022 Jan; 7(1):23. PubMed ID: 34983671
[TBL] [Abstract][Full Text] [Related]
10. Impact of Age and Antibody Type on Progression From Single to Multiple Autoantibodies in Type 1 Diabetes Relatives.
Bosi E; Boulware DC; Becker DJ; Buckner JH; Geyer S; Gottlieb PA; Henderson C; Kinderman A; Sosenko JM; Steck AK; Bingley PJ;
J Clin Endocrinol Metab; 2017 Aug; 102(8):2881-2886. PubMed ID: 28531305
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years.
Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033
[TBL] [Abstract][Full Text] [Related]
12. Human leukocyte antigen identity and DQ risk alleles in autoantibody-positive siblings of children with IDDM are associated with reduced early insulin response. Childhood Diabetes in Finland (DiMe) Study Group.
Veijola R; Vähäsalo P; Tuomilehto-Wolf E; Reijonen H; Kulmala P; Ilonen J; Akerblom HK; Knip M
Diabetes; 1995 Sep; 44(9):1021-8. PubMed ID: 7657023
[TBL] [Abstract][Full Text] [Related]
13. Glutamate decarboxylase (GAD65) and tyrosine phosphatase-like protein (IA-2) autoantibodies index in a regional population is related to glucose intolerance and body mass index.
Rolandsson O; Hägg E; Hampe C; Sullivan EP; Nilsson M; Jansson G; Hallmans G; Lernmark A
Diabetologia; 1999 May; 42(5):555-9. PubMed ID: 10333047
[TBL] [Abstract][Full Text] [Related]
14. Gestational respiratory infections interacting with offspring HLA and CTLA-4 modifies incident β-cell autoantibodies.
Lynch KF; Lee HS; Törn C; Vehik K; Krischer JP; Larsson HE; Haller MJ; Hagopian WA; Rewers MJ; She JX; Simell OG; Toppari J; Ziegler AG; Akolkar B; Hyöty H; Bonifacio E; Lernmark Å;
J Autoimmun; 2018 Jan; 86():93-103. PubMed ID: 28941965
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese.
Yang L; Luo S; Huang G; Peng J; Li X; Yan X; Lin J; Wenzlau JM; Davidson HW; Hutton JC; Zhou Z
Diabetes Metab Res Rev; 2010 Oct; 26(7):579-84. PubMed ID: 20842762
[TBL] [Abstract][Full Text] [Related]
16. Could ZnT8 antibodies replace ICA, GAD, IA2 and insulin antibodies in the diagnosis of type 1 diabetes?
Lounici Boudiaf A; Bouziane D; Smara M; Meddour Y; Haffaf EM; Oudjit B; Chaib Mamouzi S; Aouichat Bouguerra S
Curr Res Transl Med; 2018 Mar; 66(1):1-7. PubMed ID: 29487039
[TBL] [Abstract][Full Text] [Related]
17. Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.
Gorus FK; Balti EV; Vermeulen I; Demeester S; Van Dalem A; Costa O; Dorchy H; Tenoutasse S; Mouraux T; De Block C; Gillard P; Decochez K; Wenzlau JM; Hutton JC; Pipeleers DG; Weets I;
Clin Exp Immunol; 2013 Jan; 171(1):82-90. PubMed ID: 23199327
[TBL] [Abstract][Full Text] [Related]
18. Insulin secretion and sensitivity in the prediction of type 1 diabetes in children with advanced β-cell autoimmunity.
Siljander HT; Hermann R; Hekkala A; Lähde J; Tanner L; Keskinen P; Ilonen J; Simell O; Veijola R; Knip M
Eur J Endocrinol; 2013 Oct; 169(4):479-85. PubMed ID: 23904276
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
[TBL] [Abstract][Full Text] [Related]
20. Analysis of pathogenesis of juvenile new-onset diabetes.
Wang J; Miao D; Wang Y; Lu B; Babu S; Klingensmith G; Rewers M; Eisenbarth GS; Yu L
J Diabetes; 2011 Jun; 3(2):132-7. PubMed ID: 21138544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
